Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta
C
C
Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, Italy.
Casagranda
I
I
Semino
G
G
Moroni
M
M
Ratto
C
C
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D002277:Carcinoma / Q000188:drug therapy* / Q000601:surgery; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000139:chemically induced*; D015409:Mastectomy, Radical; D008727:Methotrexate / Q000008:administration & dosage; D009378:Neoplasms, Multiple Primary / Q000601:surgery; D016609:Neoplasms, Second Primary / Q000139:chemically induced*
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate